FDA — authorised 27 March 1985
- Application: NDA019339
- Marketing authorisation holder: HOSPIRA
- Local brand name: HEPARIN SODIUM 10,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA authorised Heparin Sodium In Plastic Container on 27 March 1985
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 27 March 1985; FDA has authorised it.
HOSPIRA holds the US marketing authorisation.